ASX
Prescient Therapeutics Limited
PTX:ASX•Healthcare
Sensitive ASX Announcement
IND for Phase 1b/2 Ovarian Cancer Trial Transferred to PTX
Published: 29/06/15, 09:22am (AEST)•2 pages